Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy

被引:6
|
作者
Kang, Seung Hyun [1 ]
Lee, Chang-Han [1 ,2 ,3 ,4 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 03080, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea
[3] SNU, Wide River Inst Immunol WRII, Hongcheon 25159, South Korea
[4] Seoul Natl Univ, Coll Med, SNU Dementia Res Ctr, Seoul 03080, South Korea
关键词
therapeutic antibody; antibody engineering; Fc engineering; bispecific antibody; FC-GAMMA RECEPTORS; MEMORY B-CELLS; MONOCLONAL-ANTIBODIES; IN-VIVO; ENGINEERED ANTIBODY; R-BINDING; HALF-LIFE; CLINICAL DEVELOPMENT; AFFINITY MATURATION; EFFECTOR FUNCTIONS;
D O I
10.1007/s12257-020-0181-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used, but recently, the engineered antibodies with various strategies according to the role of the therapeutic antibody have been used to maximize the therapeutic efficacy. In this review paper, first, the overall structural features and functional characteristics of antibody IgG, second, the old and new techniques for antibody discovery, and finally, several antibody engineering strategies for maximizing therapeutic efficacy according to the role of a therapeutic antibody will be introduced.
引用
收藏
页码:295 / 311
页数:17
相关论文
共 50 条
  • [21] Glycoengineering of Therapeutic Antibodies
    Klein, C.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 : S4 - S5
  • [22] Recombinant therapeutic antibodies
    Duebel, Stefan
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 74 (04) : 723 - 729
  • [23] Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies
    Satoh, Mitsuo
    Iida, Shigeru
    Shitara, Kenya
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1161 - 1173
  • [24] New structural formats of therapeutic antibodies for rheumatology
    Dumet, Christophe
    Pottier, Jeremy
    Gouilleux, Valerie
    Watier, Herve
    JOINT BONE SPINE, 2018, 85 (01) : 43 - 48
  • [25] Tailoring immunoglobulin Fc for highly potent and serum-stable therapeutic antibodies
    Jung, Sang Taek
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2013, 18 (04) : 625 - 636
  • [26] An In Vitro Model That Predicts the Therapeutic Efficacy of Immunomodulatory Antibodies
    Dal, Min
    Yip, Yuen Yee
    Hellstrom, Ingegerd
    Hellstrom, Karl Erik
    JOURNAL OF IMMUNOTHERAPY, 2016, 39 (08) : 298 - 305
  • [27] Biparatopic antibodies: therapeutic applications and prospects
    Niquille, David L.
    Fitzgerald, Kyle M.
    Gera, Nimish
    MABS, 2024, 16 (01)
  • [28] Barriers for orally inhaled therapeutic antibodies
    Secher, Thomas
    Heuze-Vourc'h, Nathalie
    EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (08) : 1071 - 1084
  • [29] The pharmacology and therapeutic applications of monoclonal antibodies
    Castelli, Maria Sofia
    McGonigle, Paul
    Hornby, Pamela J.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (06): : e00535
  • [30] Therapeutic antibodies for infectious diseases
    Sparrow, Erin
    Friede, Martin
    Sheikh, Mohamud
    Torvaldsen, Siranda
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2017, 95 (03) : 235 - 237